Bulletin
Investor Alert

Aphria Inc.

NYS: APHA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 22, 2020, 7:59 p.m.

/zigman2/quotes/207425803/composite

$

4.01

Change

-0.03 -0.74%

Volume

Volume 64,658

Quotes are delayed by 20 min

/zigman2/quotes/207425803/composite

Previous close

$ 3.95

$ 4.04

Change

+0.09 +2.28%

Day low

Day high

$3.73

$4.09

Open

52 week low

52 week high

$1.95

$7.68

Open

Company Description

Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The D...

Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.

Valuation

Price to Sales Ratio

9.14

Price to Book Ratio

1.31

Enterprise Value to EBITDA

-12.29

Enterprise Value to Sales

2.12

Total Debt to Enterprise Value

0.23

Efficiency

Revenue/Employee

382,435.00

Income Per Employee

-26,611.00

Receivables Turnover

4.57

Total Asset Turnover

0.13

Liquidity

Current Ratio

5.64

Quick Ratio

4.84

Cash Ratio

4.12

Profitability

Gross Margin

8.74

Operating Margin

-47.45

Pretax Margin

-6.12

Net Margin

-6.96

Return on Assets

-0.87

Return on Equity

-1.15

Return on Total Capital

-6.57

Return on Invested Capital

-0.98

Capital Structure

Total Debt to Total Equity

28.66

Total Debt to Total Capital

22.28

Total Debt to Total Assets

19.76

Long-Term Debt to Equity

28.29

Long-Term Debt to Total Capital

21.99

Officers and Executives

Name Age Officer Since Title
Mr. Irwin David Simon 60 2018 Chairman
Mr. James R. Meiers - 2019 Chief Operating Officer-Aphria Leamington
Mr. Carl A. Merton - 2014 Director
Mr. Jamie Policella - - Director-Information Technology
Mr. Tim Purdie - 2019 Chief Information & Information Security Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
/news/latest/company/us/apha

MarketWatch News on APHA

  1. When to Expect Profits From Canada’s Pot Producers

    11:19 a.m. May 8, 2020

    - Barron's Online

  2. SEC Charges Marijuana Stock Investors With Fraud

    11:53 a.m. April 17, 2020

    - Barron's Online

  3. Buy Marijuana Stock Aphria, Sell Tilray, Analysts Say

    12:03 p.m. April 16, 2020

    - Barron's Online

  4. Cannabis Producer Aphria Reports Strong Earnings, Crushing Its Rivals

    12:31 p.m. April 15, 2020

    - Barron's Online

  5. Pot Stocks React Differently After Earnings

    7:51 p.m. March 30, 2020

    - Barron's Online

  6. Pot stocks plunge after another round of disappointing earnings

    2:48 p.m. March 30, 2020

    - Max A. Cherney

  7. Aphria started at hold with C$4.50 stock price target at Stifel Nicolaus

    7:17 a.m. March 10, 2020

    - Tomi Kilgore

  8. Aphria's stock runs up 11% in premarket trading

    7:57 a.m. Feb. 14, 2020

    - Tomi Kilgore

  9. Loading more headlines...
/news/nonmarketwatch/company/us/apha

Other News on APHA

  1. BofA back on board with Canopy Growth

    7:23 a.m. May 22, 2020

    - Seeking Alpha

  2. Aphria Stock Floats on Liquidity While Competitors Stumble

    7:40 a.m. May 21, 2020

    - 247WallSt.com

  3. 4 Marijuana Stocks to Buy for the Big 2020 Rebound

    5:05 p.m. May 19, 2020

    - InvestorPlace.com

  4. Aurora Cannabis: Whether We've Seen The Bottom

    10:22 a.m. May 19, 2020

    - Seeking Alpha

  5. Myriad's (MYGN) EndoPredict Grows Amid Coronavirus Mayhem

    11:55 a.m. May 18, 2020

    - Zacks.com

  6. Here's Why You Should Retain Masimo Stock (MASI) For Now

    11:11 a.m. May 18, 2020

    - Zacks.com

  7. Aurora Cannabis leads pot stock rally

    10:37 a.m. May 18, 2020

    - Seeking Alpha

  8. Loading more headlines...

At a Glance

Aphria, Inc.

265 Talbot Street West

Leamington, Ontario N8H 4H3

Phone

1 8444274742

Industry

Pharmaceuticals

Sector

Health Care/Life Sciences

Fiscal Year-end

05/2020

Revenue

$237.11M

Net Income

$-16.50M

2019 Sales Growth

542.3%

Employees

620.00

/news/pressrelease/company/us/apha

Press Releases on APHA

  1. Psychedelics Strive to Emulate Cannabis' Path to Legality

    9:00 a.m. May 13, 2020

    - PR Newswire - PRF

  2. Lawmakers Take Steps to Decriminalize Psychedelic Mushrooms

    9:00 a.m. May 7, 2020

    - PR Newswire - PRF

  3. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.